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Abstract 
In recent years, progresses in nanotechnology have established the foundations for implementing 
nanomachines capable of carrying out simple but significant tasks. Under this stimulus, researchers have been 
proposing various solutions for realizing nanoscale communications, considering both electromagnetic and 
biological communications. Their aim is to extend the capabilities of nanodevices, so as to enable the execution 
of more complex tasks by means of mutual coordination, achievable through communications. However, 
although most of these proposals show how devices can communicate at the nanoscales, they leave in the 
background specific applications of these new technologies. Thus, this paper shows an overview of the actual 
and potential applications that can rely on a specific class of such communications techniques, commonly 
referred to as molecular communications. In particular, we focus on health-related applications. This decision 
is due to the rapidly increasing interests of research communities and companies to minimally invasive, 
biocompatible, and targeted health-care solutions. Molecular communication techniques have actually the 
potentials of becoming the main technology for implementing advanced medical solution. Hence, in this paper 
we provide a taxonomy of potential applications, illustrate them in some details, along with the existing open 
challenges for them to be actually deployed, and draw future perspectives. 
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1. Introduction 
In recent years, nanoscale communications have inspired a huge research effort in many fields [1][2][3], 
including medical science [4][5], environmental control, and material science. Research activities have focused 
on different types of nanomachines, from those based on carbon nanotubes and carbon nanowires [6] to 
biological ones [7][8]. Due to the heterogeneity of environments and communication techniques exploitable 
at the nanoscales, it is unfeasible to identify general models, valid for most of nano-communication 
technologies [9], such as terahertz communications [10], neuronal communications [11], and molecular 
communications [12]. In fact, context and micro-environmental features have a deep influence on the models 
of each communication scenario. For this reason, an extensive literature relevant to the analysis of different 
innovative communication solutions at the nanoscales exists.  
Molecular communications have received a lot of attention since they are considered an alternative 
approach to electromagnetic communications due to their unique features of biocompatibility and minimal 
invasiveness, which are essential for them to be used in living bodies. This class of communications takes 
inspiration from some existing communication mechanisms between biological entities. It consists of using 
relatively small molecules, such as hormones and other small proteins (e.g. cytokines), peptides, 
carbohydrates, lipids and combinations of them, which can propagate from a transmitter to receivers. The 
response of such communicating biological entities (i.e. natural and/or artificial cells) is highly specialized. 
Indeed, receivers must recognize different signals associated with different molecules received through their 
specialized membrane receptors. Actually, the cell membrane may contain hundreds or thousands of receptor 
molecules for each type of compatible ligand. Depending on the signals (i.e. types of molecules) received by 
a cell, different behaviors are triggered [14]. By exploiting these communication mechanisms, the ongoing 
research on molecular communications is highly oriented to expanding capabilities of nanodevices, by 
enabling the execution of complex tasks through their coordination. However, many proposals are essentially 
focused on design and analysis of communications techniques and protocols at the nanoscales, often without 
a sound analysis of the wide set of applications that can benefit from these proposals. The essential contribution 
of this works is to identify and classify the applications that can benefit from nanoscale molecular 
communications in the medical field. A contribution on this subject can be found in [4], although at a very 
early stage. It is also worth to mention the paper [13], which is a survey of nanotechnology applications for 
health care, but it does not include any discussion on the potential applications and benefits achievable by the 
introduction of molecular communications. Hence, this survey contributes to organize and classify the medical 
scenarios that are believed to significantly benefit from this kind of communications. Although full-fledged 
artificial biological nanomachines are far from being considered ready for systematic production and 
exploitation [15], biochemists have achieved significant milestones, such as the creation of cell components, 
such as artificial ribosomes, which can be used for the artificial synthesis of proteins [7][8]. In addition, the 
theoretical and computational models of biological circuits enabling molecular communication have already 
been assessed [16].  
  
Some realistic results achievable in the mid-term consist of emulating nanoscale biological processes 
through computational intensive simulation platforms [17]. This way, it is possible to realize personalized 
predictions of the evolution/trajectories of diseases, starting from a limited number of biomarkers1, without the 
need of executing the traditional in-vivo tests on patients [18][19]. The computational models are based on a 
detailed characterization of the molecular communication parameters done by using results of in-vitro and 
in-vivo experiments. The key aspect of this approach is translating general experimental results in numerical 
functions that can be parameterized through marker values relevant to each individual patient, so as to produce 
a personalized medical characterization of a patient, including risk assessments, thus helping medical 
personnel to identify optimal treatments. 
An example of longer-term objectives of nanoscale communications consist of designing and implementing 
nano-sensors and nano-actuators for the prevention, detection, and treatment of a large set of diseases, such as 
cardiovascular diseases or tumors. For instance, specific proteins can be delivered for activating the immune 
system and/or triggering drug delivery systems in small specific areas without affecting the rest of the body. 
In addition, real-time monitoring of biological parameters during the execution of these innovative techniques 
can be integrated by an information exchange with the outer world. In this respect, a fundamental research 
activity consists of the design of communication protocols handling both intra-body communications and 
information exchange with the external through special interfaces. Recent advancements on this subject has 
brought insights on the development of body area nanonetworks able to make localized or remote decisions 
on the treatment of complex diseases [4]. 
Figure 1 shows a taxonomy of the main applications in nanomedicine supported by ICT. The first distinction 
is between techniques oriented to diagnosis and those oriented to treatment. Application developed for 
diagnostic purposes are further classified in disease detection applications, personalized applications for a 
detailed diagnosis after the initial disease detection, and advanced imaging techniques. For what concerns 
treatment applications, we have identified applications designed for drug delivery, tissue engineering, 
nanosurgery, and controlled triggering of the portions of the immune system. In addition, some applications 
can be further specialized by functions, such as run time monitoring, control, and activation/delivery, and be 
embedded in a temporal logic. Clearly, boundaries between diagnosis and treatment are blurring (predictive 
and preventable medicine), and the two fields overlap. However, this taxonomy allows associating the suitable 
technology with each application field. 
The paper is organized as follows. Section 2 focuses on diagnostic applications. Different monitoring 
techniques for both general biological conditions and specific diseases are illustrated. In Section 3, we describe 
applications of nanocommunication systems for advanced treatments. In Section 4, we present some 
                                                            
1 A biomarker is a traceable substance that is introduced into an organism as a means to analyze some health-related 
aspects, or a substance whose detection indicates a particular disease state. In this work, we will refer to biomarkers as 
the second definition. Specifically, a biomarker indicates a change in expression or state of a protein that correlates with 
the risk or progression of a disease, or with the susceptibility of the disease to a given treatment. 
  
implementation mechanisms and interfaces currently under study. Section 5 draws future research challenges 
of molecular communications for medical purposes, followed by our conclusions in Section 6.  
 
 
Figure 1: A taxonomy of potential applications of molecular communications to nanomedicine.  
 
2. Diagnostic Applications 
In this section we illustrate some applications proposed for diagnostic purposes. We focus on disease 
detection in subsection 2.1, in particular on tumor detection. Then, in subsection 2.2, we explore the field of 
personalized diagnosis, where the combination of advanced simulation techniques and limited clinical exams 
  
allows implementing personalized health monitoring tools and personalized determination of risk assessment. 
Finally, in subsection 2.3, we focus on the imaging techniques and show how their accuracy can benefit of the 
deployment of molecular communications techniques. 
2.1. Disease Detection 
A promising application area for the nanoscale communications is that of the diagnosis of diseases. For 
instance, the identification of tumors is particularly well suited to be achieved through molecular 
communications [20][21]. The basic idea consists of monitoring the concentration of specific biomarkers in 
the cardiocirculatory system. This way, it is possible to detect different cancer types in their early stages. 
Clearly, this approach is not limited to tumors and can be successfully applied to other critical diseases. 
Some proposals consist of the development of nanorobots, which can be dragged towards the tumor site by 
flagellated bacteria attached to them, since the latter can be attracted by some proteins secreted by tumors. A 
graphical representation of this application is shown in Figure 2. A further step consists of making such 
nanorobots able to release a given amount of medicine directly on the desired location (drug delivery), or 
release signals for other bionanomachines, which have to be taken out of the body (see Section 4). The 
chemotactic capability of these bacteria induces a higher migration speed toward tumor cell lysates than toward 
normal cells. These results have been verified through a set of in-vitro and in-vivo experiments [22]. It is also 
possible to take advantage of this ability for monitoring the spread of the tumor cells and to implement a 
targeted drug directly on diseased cells thus reducing side effects [22]. For this purpose, it was also proposed 
to attach a set of polystyrene microbeads on the bacterial surface [23][24][25]. In this way, it is possible to 
develop various types of bacteria-based microrobots by using compatible materials able to bind with the 
polystyrene beads.  
 
Figure 2: Nanorobots dragged towards the tumor site by flagellated bacteria attached to them; bacteria are attracted by some proteins 
secreted by tumors.  
  
Another major strand of research is the detection of tumors by sensing abnormal concentration of 
circulating tumor cells (CTC) in the blood stream, that contribute to the spread of tumors throughout the body. 
Whilst in healthy immune conditions a minimal presence of CTC may be found in the blood stream, and the 
immune system is typically able to remove them, when a cancer has started to develop, CTCs originate 
massively from the primary tumor site and, through the bloodstream, may propagate in any part of the body, 
generating the so-called metastases if suitable conditions are found. Hence the concentration of such cells in 
the bloodstream gives useful diagnostic and prognostic information about the location and progression of a 
tumor. The monitoring of the CTC concentration allows both an early detection of a disease both in its initial 
phase and any at any relapse of it after an apparently successful treatment. Each CTC exposes several 
biomarkers on its surface that are useful for the cell detection. One of the most important biomarker is the 
CD47 that is in general over-expressed by the tumoral cells to fool the immune system and avoid to be 
destroyed by macrophages [26][27]. 
Other biomarkers can be used for detecting CTCs include the circulating microRNA-101 for the 
hepatocellular carcinoma [28], the carcinoembryonic antigen (CEA) for different types of lung cancer [29], 
the CD164 protein for the ovarian cancer [30], the apolipoprotein C-II for the cervical cancer [31], the plasma 
osteopontin for non-small cell lung cancer [32], and the plectin for the pancreatic cancer [33]. All these markers 
are expressed over the surface of CTCs, which are slightly larger than white blood cells (they seem also to 
detach from the primary tumours in groups). It may also happen that CTCs spread their DNA throughout the 
circulatory system by using microvesicles/exosomes as transport vector [34]. By the simultaneous detection 
of different types of biomarkers it is possible to identify different cancer types and their stage with a high 
degree of accuracy, thus obtaining also information about the location of the tumor. It is likely that risk 
ascertainment methodologies will rely on networks of markers or markers that will undergo remodulation in 
different progression of the disease. 
Molecular communications have a central role for real-time detecting CTCs by using implanted devices. 
Detection can happen by either using contact-based communications [35], or by absorbing 
microvesicles/exosomes transporting RNA-i strands of the tumor emitted by CTCs [36]. Since the 
concentration of these cells could be very small in the early stages of a disease, it is necessary to collect some 
evidences in order to reliably estimate a higher than normal concentration. For increasing the detection 
probability, some proposals are based on the use of circulating mobile nano-sensors. For each individual CTC 
detection, they are designed for releasing bursts of signaling molecules that are collected by a sink, likely 
located in an implanted device in the circulatory system. In turn, this sink (e.g. the smart probe presented in 
Section 4) can deliver the collected information to the external by means different communication techniques. 
A high level illustration of this approach is shown in Figure 3. An alternative, although more complex solution, 
consists of processing the collected information locally, in sink nano-controllers or even in the detecting nano-
sensors. We note that further improvements could rely on detection of both CTCs and free tumoral DNA in 
the blood. 
  
 
 
Figure 3: A schematic illustration of CTC detection assisted by molecular communications: a) nano-sensor-CTC interaction; b) nano-
sensor interacting with a damaged vessel and/or fixed cell (e.g., a tumor); c) nano-sensor/nano-controller collecting bursts of signaling 
molecules released by cells or other nano-sensors; d) nano-sensor interacting with a smart probe to export collected information. 
 
A further approach for (liver) tumor diagnosis, which makes use of molecular communications outside of 
the cardiocirculatory system, is to engineer microbes that are well tolerated by patients and that can be 
integrated with existing clinical methods. In [37], the authors make use of the safe probiotic Escherichia coli 
Nissle 1917 to develop an orally administered diagnostic that can indicate the presence of liver metastasis by 
producing easily detectable signals in urine. In fact, the used bacteria generate a high-contrast urine signal 
through selective expansion in liver metastases and trigger the production of a small molecule that can be 
detected in urine. The used bacterium colonizes tumor tissues in rodent models of liver metastasis without 
colonizing healthy organs or fibrotic liver tissue. The results in [37] demonstrate that probiotics can be 
programmed to safely and selectively deliver synthetic gene circuits to diseased tissue microenvironments. 
Another approach which takes advantage of molecular communications for tumor detection consists of 
using a smart sensor chip for improving efficiency and accuracy of prostate cancer detaction [38]. This 
approach do not involve the cardiocirculatory system, but leverages molecular communications in external 
devices. The sensor chip illustrated in [38] can both pick up differences in glycoprotein molecules and help 
early stage cancer diagnosis. Glycoprotein molecules play a key role in the immune response, thus they are 
useful biomarkers for detecting prostate cancer and other diseases. The sensor chip in [38] includes synthetic 
  
molecular communications receptors of specific glycoprotein molecules that are differentiated by their 
modified carbohydrate chains.  
2.2. Personalized Diagnosis 
Through the combination of interdisciplinary expertises, coming from the medical, engineering, and 
computer science research fields, it is envisaged the development of an innovative prevention approach based 
on a personalized risk assessment procedure. Indeed, due to the availability of technical information through 
the internet, the advancement in the medicine field has led also to an involvement of the patients in the health 
care process in order to give them a unique knowledge of their own health status2. This knowledge will let 
each patient to take part in each step of the therapeutic process and allow the delivery of information between 
medical staff, promoting the medical coordination and reducing possible errors. On this context, the model of 
P6 medicine [19], initially proposed by Leroy Hood as P4 (Predictive, personalized, preventive, participatory) 
model [18], has achieved a substantial consensus. P6 medicine is defined as participatory, personalized, 
predictive, preventive, psycho-cognitive and public. The strategic objective of a personalized diagnosis assisted 
by molecular communication is the definition, design, implementation, and experimental assessment of a not 
invasive and radically new method for assessing the risk of several diseases in the human body (e.g. 
cardiovascular diseases and many others). 
In this context, solutions for monitoring of the evolution of the atherosclerosis, by dealing with the low-
level mechanisms that govern its formation (atherogenesis) and its evolution, can be found in [39] and [40]. 
They can clearly be extended to other pathologies, such as diabetes. Essentially, extensive usage of massive 
computational resources and theoretical models are used for emulating the behaviour of cells (mainly platelets 
and white blood cells) and nanoparticles (mainly CD40L [41]) circulating in microcirculation, interacting both 
with each other and with endothelial cells of the blood vessels and responsible to be the cause of atherogenesis 
[42][43]). Through the design of specific computational methods it is possible to simulate the mechanisms 
leading to the development of atheroma within the inside lining of arteries and their subsequent hardening. A 
further development could be the in-silico emulation of the process of artery narrowing, which can have a 
major effect on blood flow, ultimately leading to the total closure of vessels that may cause diseases such as, 
angina, myocardial infarction, stroke, and critical limb ischemia, depending on the site of the atheroma. 
Clearly, the in-silico emulation has to be previously tuned by means of the analysis of the outcomes of a 
number of in-vitro/in-vivo experiments [44][45][40], in order to validate the simulation platform, and to make 
it so robust to be easily parameterized by means of a limited number of parameters, which can be extracted by 
standard lab examinations. Figure 4 shows the mapping of traditional communications systems elements onto 
the biological ones [45]. 
                                                            
2 Here we note that data ownership will be a debatable topic. 
  
 
Figure 4: Mapping of the molecular signaling system in blood vessels onto the telecommunications counterpart. 
 
The potentials of this approach consists of higher capabilities of determining one individual’s actual 
cardiovascular risk if compared to current approaches with the final aim to increase the awareness of the actual 
risk of each individual subject so as to deploy suitable and personalized medical treatment that will bring to 
significant benefits in terms of: 
- reduction of mortality and morbidity due to cardiovascular diseases; 
- possibility of reducing time-consuming and potentially invasive cardiovascular diagnostic 
investigations  and thus to improve the quality of life of patients; 
- reduction of iatrogenic disease due to unnecessary/inappropriate preventive therapies; 
- significant decrease of national health service expenditures. 
From the medical perspective, it is necessary to carefully identify and measure all the significant biological 
and pathological processes involved in the development of atherothrombosis, and in particular the complex 
cell-cell interactions that take place in vivo during atherogenesis and arterial thrombosis, and to assess, their 
mutual influence and evolution [39]. Clearly, understanding which molecular communications take place, at 
which extent, and with which impact on atheroma formation, would be a major issue in this process. 
  
The approach proposed in [39] aims to translate these processes in algorithms and to organize them within 
a suitable comprehensive simulator. The complexity of this simulator, although necessarily high, must allow 
its management through innovative ICT theories and technologies, and will certainly involve the use of the 
most powerful currently available solutions of distributed and cloud computing. 
 
2.3. Imaging 
An interesting nanoscale communication application is the visualization of biological parameters, based on 
fluorescent molecules, i.e. fluorophores, as transmitting and receiving nanomachines. These special molecules 
can be excited by optical, electrical, chemical or biological energy, and individually relax to the ground state 
after a random time. The excited-state of the donor can be suppressed in many ways, switching off the 
fluorescence. For example, a collision with excited donor may cause the quenching of the fluorescence, 
dissipating the energy through heat without the emission of photons. 
In particular, quantum dots (QDs), which are tiny light-emitting particles at the nanometer scale, are 
emerging as a new class of fluorescent probes for in vivo biomolecular and cellular imaging. In comparison 
with organic dyes and fluorescent proteins, QDs have some advantages due to optical and electronic features: 
size-tunable light emission, improved signal brightness, resistance against photobleaching, and simultaneous 
excitation of multiple fluorescence colors. QDs have opened new possibilities for ultrasensitive and 
multiplexed imaging of molecular targets in living cells, animal models and, possibly, in humans [46], with 
increased accuracy compared to the classic imaging techniques. 
A deeply analyzed quenching mechanism is the Förster resonance energy transfer (FRET), which is based 
on the migration of the excited-state energy, in the form of exciton, from the donor molecule to a ground-state 
acceptor molecule. In this case, the donor does not fluoresce, and the acceptor non-radiatively becomes excited 
by receiving the donor's exciton [47]. The FRET approach has inspired a sort of short-range communications, 
in which the information are encoded into the excited-states of the fluorophores, and then are transferred via 
FRET mechanism between a donor fluorophore and an acceptor fluorophore, one acting as a transmitter 
antenna and the other as a receiver one. 
Through the excitation of the fluorophore by a laser, with a wavelength in the range of donor's absorption 
spectrum and using the on-off keying modulation scheme, it was analyzed also the channel capacity [48]. The 
simulation results showed that it is possible to achieve transmission rates up to 10Mbps over short 
communication ranges, [49]. In [50], the authors propose a FRET-based mobile molecular sensor/actuator 
network (FRET-MSAN) composed of a set of sensors, i.e. bioluminescent molecules that are excited upon 
binding a target molecule and actuators, which can realize a specific task after proper excitation.  
In general, bioluminescent molecules do not require an external excitation source, since they may react 
with endogenous elements, such as calcium ions, and release a photon. For example, in [51] Quantum Dots-
  
DNA (QDs-DNA) nanosensors based on FRET are used to detect target DNA and single mismatch in Hepatitis 
B Virus (HBV) gene. 
An interesting active targeting solution is given by the aptamers, known as "chemical antibodies" due to 
their functional similarities [52]. The aptamers are composed by single-stranded RNA or DNA nucleic acids 
that allow the recognition and binding to specific targets with a high degree of specificity and affinity. 
Moreover, they have higher thermal stability, faster tissue penetration, low-cost chemical synthesis than their 
natural counterpart. Targeted imaging is a possible application of aptamers. In fact, they could be combined 
with imaging nanomaterials, radionuclide probes (e.g. magnetic nanomaterials used in magnetic resonance 
imaging) or even QDs to reach a specific target and improve accuracy of imaging. Clearly the molecular 
imaging (for example intravital) together with the medical imaging will provide impressive capability to the 
diagnosis. 
Another interesting proposal for smart imaging consists of the so-called “virtual biopsy” [53]. It is 
implemented through a biodegradable, nano-sized polymer, which is armed with tracers that detect cancer 
biomarkers. Visible on a magnetic resonance imaging test, tracers accumulate at the cancer site and diagnose 
the type of cells (e.g. breast). After this “virtual biopsy”, a drug delivery system, equipped with drugs tailored 
to the specific mutations, can deliver them to the tumor (see section 3.1). The authors claim that this technique 
can be applied also to brain tumors [53], which are notoriously difficult to treat. In particular, the molecular 
structures of most chemotherapy drugs are too large to penetrate the blood-brain barrier, which is the system 
of protective blood vessels that surround brain. 
3. Treatment of Diseases 
One of the most interesting class of applications of molecular communications is the detection and 
treatment of diseases, with special focus on tumors. Further applications on health care include immune system 
triggering, with applications not only to tumors, but also to other localized diseases (e.g. inflammations), tissue 
engineering in regenerative medicine, and nanosurgery. 
3.1. Drug Delivery 
One of the most popular topics in nanomedicine is the targeted drug delivery, since it could be the basis for 
the modern medical therapeutics. Its main goal is to provide a localized drug delivery only where medication 
is needed, thus avoiding to affect other healthy parts of the body. This is due to the very small size of the 
particles delivering medicine, which is in the order of nanometers, which allow them to diffuse into the 
bloodstream and across the vascular and interstitial barriers.  
Many types of drug delivery, based on the molecular communications, have been proposed in the technical 
literature, with both passive and active transport of molecules. For what concerns passive transport, the most 
popular approach is based on particle diffusion, with or without drift. In case the drug delivery happens via the 
cardiocirculatory or lymphatic system, the most appropriate model is the diffusion with drift, by also 
  
considering the effect of collisions with blood cells [40][39]. In case the drug delivery happens outside blood 
vessels, e.g. in the extracellular matrix, the mere diffusion-based model is sufficiently accurate. In case of 
active transport, the main alternatives are those based on bacteria or molecular motors. 
In order to design an efficient and targeted delivery, it is essential to correctly determine the distribution of 
particles over time. For this reason, the relevant research has produced several approaches, from statistical 
models [54][55] to analytical ones [56]. In particular, drugs delivered through bloodstream can reach any part 
of the body, by passing through the complex network of blood vessels (Particulate Drug Delivery System, 
PDDS). In [56] the authors propose a specific model of the cardiovascular system, by analyzing the 
peculiarities of different vessels, from the smallest to the largest ones, thus obtaining a drug propagation 
network model, which takes into account even bifurcations and junctions of vessels. The resulting model 
includes also the individual features of the cardiovascular system by physiological parameters, such as the 
heartbeat rate profile. This model could be useful to guarantee that the drug concentration does not reach toxic 
levels in the body and it is a essential for optimizing the drug injection, by identifying the suitable injection 
points that guarantee the best delivery profile for maximizing the treatment benefits while minimizing the 
amount of drugs in the other parts of the body. To this aim, it is necessary to realize a complete control of the 
drug release, from the initial release, to the suitable release rate.  
A theoretical model on the local rate control between a nano-controller and a nano-actuator, not involving 
drug propagation in the cardiocirculatory system (local drug delivery system), has been presented in [57]. 
Subsequently, a related communication protocol, inspired by the TCP congestion control, has been proposed 
in [58]. This protocol can control the drug release process by using feedback messages. A challenging aspect 
of the protocol operation is that feedback messages, in some cases, can be transmitted even in situation where 
a drift of the communication medium is present. A detailed discussion of the conditions that enable this type 
of communication is presented in [59]. 
Even real time monitoring of the drug concentration is very important. Indeed, as illustrated for CTC 
monitoring, a set of nanomachines able to recognize specific drug molecules could take decisions based on the 
measured levels of their concentration. This way, it is possible to control the drug release rate and, at the same 
time, to deliver the collected information outside, through specific interfaces, as illustrated in Section 4. 
In synthesis, we can identify three main challenging functions, and associated entities, related to drug 
delivery, (see Figure 1): 
- Delivery: It is the function of releasing drugs, realized by nano-actuators. Delivery can be either 
systemic, as proposed in [56], or localized, as mentioned in [57][58]. In the first case, in order to avoid 
side effects, a preliminary configuration and provisioning of the system is needed to regulate the 
amount of drug to release. For realizing a localized delivery, additional entities are necessary, as 
explained below; 
  
- Monitoring: It is the function monitoring the release rate of the drug for it to be effective. It can be 
implemented by a monitoring device communicating with the target (e.g. a tumor), or by deploying on 
a monitoring device, located near to the target, some receptors able to absorb part of the drug. 
Depending on either the absorption rate measured by such a monitoring node, or evaluated by 
processing the information received through a molecular communication channel with the target (e.g. 
via contact-based communications), the control node can take appropriate actions. In fact, an excessive 
amount of drug should be avoided not only for its undesirable side effects, but also for its possible 
wastage, as it happens in case of receiver/channel congestion [57][58]; 
- Control: the control node is a nano-node in charge of regulating the drug release rate at the nano-
actuator. It can be implemented as a separate nano-node, or co-located with the monitoring node. It can 
trigger variations in the release rate of the nano-actuator by means of feedback messages, transmitted 
by using molecules different from those of the monitored drug [57][58]. The control node is also in 
charge to start and stop the drug release, upon specific local conditions, thus implementing a sort of 
connection-oriented communications [58]. 
The functions mentioned above and their implementation by means of molecular communications are 
illustrated in Figure 5.  
 
 
Figure 5: A general model of a drug delivery system: D is the actuator nano-node, in charge of delivering drugs (red particles); M/C is 
a monitor and/ control nano-node, in charge of measuring the effects of drugs on the Target by measuring specific quantities (green 
particles), and to control the emission rate of D via feedback signals (blue particles). 
 
3.1.1. Virus-based techniques 
A novel strand of research encompasses the use of virus particles as information carriers for molecular 
communication [60]. These organic particles consist of a nucleic payload (DNA or RNA), a protein coat that 
protects the information payload, and a lipid envelope that encapsulates the protein coat. This way, it is possible 
to exchange nucleic acid-based messages between nanomachines within biological environments. The protein 
coated which protects the payload may be regarded as the header of an information packet, since it implements 
  
a ligand compliant with the relevant receptors on the surface of the destination cells. This behavior is inherited 
from the basic features of the viruses, which makes them very useful in a nanoscale communication system. 
Indeed, each virus can encapsulate nucleic acid molecules and release them at long distances directly into the 
recipient cells. This property makes viruses useful for gene therapy applications. In order to increase the 
propagation distances, viruses can release the carried information into an intermediate cell, and in turn the 
infected cell spreads the infection acting as a relay node. The information encoded into the nucleic acid 
molecules contains the virus genetic information, such as the replication instructions for the infected cells. 
In [60] the authors propose the use of synthetic cells as intermediate nodes that have been engineered so as 
to forward messages to the desired destination nodes, through multihop communications, thus implementing 
a sort of multihop routing technique. The source cell contains several payload genes, which allow transmitting 
multiple payloads destined to multiple destinations by using a single-source cell. Through the use of a gene 
expression control, it is possible to silence specific aspects of the viral gene expression, thus allowing the 
control of proviral genes that are responsible for payload selection, packing, and addressing of viruses in the 
cell [61]. 
By taking advantage of the abilities of viruses, it is possible to design complex networks where the released 
messages are received only by the desired nodes, in any desired directions. The viral vectors can therefore be 
used to deliver artificial payloads (i.e. DNA plasmid) into the targeted cells, thus realizing an effective 
treatment of several diseases [62]. This method allows packaging drugs and delivering them with great benefits 
in terms of preventing both drug degradation and interaction with the biological environment, and enhancing 
drug absorption on the desired tissues.  
The paper [63] presents another technique to enhance drug absorption, even prolonging its interaction with 
the targeted tissue. Many drug types, that can be attached to a virus structure through a covalent binding, have 
been analyzed. Indeed, when viruses are used as nanocarriers, the targeting functions can be realized by 
chemically attaching the targeting domain either via bioconjugation to the exterior of the virus particles or by 
the genetically inserting  the sequence of a domain into the surface loops of the viral capsid protein. Moreover, 
viruses have a regular structure and, for this reason, their chemical and conformational structure can be 
produced in large quantity with a high degree of accuracy. 
3.1.2. Bacteria-based techniques 
Molecular communications making use of bacteria can be used for executing all the three basic functions 
mentioned in Section 3.1, with a particular focus on cancer detection and treatment. In more details, the set of 
combined bacteria-based detection and treatment techniques include circulating tumor cell (CTC) detection in 
the blood stream, injection of genetically modified bacteria in tumor mass, real time monitoring of tumor 
evolution and bacteria transcriptome, proteome, and concentration in time and body organs, and counteraction 
of inflammations due to treatment. 
  
It is known that tumors include different areas with very different concentration of oxygen, necrotic, 
hypoxic, and well-oxygenated regions. Due to the lack of oxygen, tumors with hypoxic areas are resistant to 
well-established anticancer agents and radiotherapy. On the other hand, the oxygen shortage can be exploited 
to allow anaerobic bacteria to grow inside a tumor. In particular, recent studies show the usage of an attenuated 
strain of the anaerobic bacterium Clostridium novyi. What emerged is a clear and reproducible antitumor 
response when the bacterium spores are injected into tumors. Experiments on rats, dogs, and even one human 
patient have been executed [64]. The achieved results are such to encourage a deep research on this direction. 
The idea of using bacteria to combat cancer dates back to the 1890’s, when cancer researcher William Coley 
noticed that some patients who developed postsurgical infections went into remission or were even cured of 
their disease.  
A recent research has demonstrated the feasibility of a cancer therapy based on genetically modified 
bacteria [65]. Experimental results show that bacteria are highly selective and localized within tumors [65], 
since an anaerobic microenvironment is ideal for their growth [66]. The study reveals that the modified bacteria 
prefer to replicate in tumors. Moreover, the modification allows the expression of a variety of genes coding 
for therapeutic proteins, such as tumor necrosis factor (TNF-alpha), and many others [67][68]. The molecular 
communications associated with the release of such proteins have shown a remarkable tumor regression with 
respect to the untreated tumors with such bacteria [65]. 
Although bacteria were genetically modified, some undesired side effects appeared and the effectiveness 
of this approach was questioned. A deeper research activity is needed in order to reduce the threat of bacteria 
and their specific goal, by targeting only the tumor tissues and not anything else. 
A further stand of research aiming at developing bacteria-based nanomachines able to accomplish 
diagnostic test, delicate surgeries, and cancer therapies, has brought to the design of magnetic drug carriers 
that can be guided across the blood vessels [69]. The tiny size of these nanomachines makes it difficult to 
implement a battery-powered motor. Thus, the guided propagation is obtained by equipping  nanorobots with 
metallic particles that allow driving them by an external magnetic field (e.g. by a MRI machine). Such 
nanomachines can be obtained by using the MC-1 bacterium, which is a perfect carrier for anticancer drugs, 
that are attached to its external surface. Another important feature of this family of bacteria, is that they are 
magnetotactic, since they have the ability to align themselves with Earth's magnetic field. This allows guiding 
bacteria by generating a weak magnetic field. The release of such bacteria could be done through bubble-like 
vesicles that carry large amounts of bacteria and magnetic nanoparticles, in order to guide them towards the 
site of interest, where bacteria are released. 
An open issue related to the use of bacteria is the effectiveness of their communications, especially when 
transmitted messages have to drive their operations. A technique that can improve the information delivery in 
bacterial nanonetworks is conjugation. It consists of forming a physical connection between bacteria in order 
to transfer DNA molecules (i.e., plasmids or chromosomes). However, the fragile physical connection between 
  
bacteria is prone to breakage, in particular under mechanical stress. In [70], a coding process for improving 
information delivery in bacterial nanonetworks is proposed and analyzed. 
3.1.3. Nanorobots 
An interesting approach for developing nanoscale-computing machines involves the use of DNA origami 
nanorobots [71]. This system can retrieve biochemical and physiological information for diagnostic purposes, 
by monitoring the fluorescent outputs associated with the robot final states. Moreover, the system is 
particularly useful for controlling therapeutic molecules in living organisms. 
The main characteristics of these robots is that they can execute these computing functions (e.g. monitoring) 
acting as a network of logic gates. In particular, they are controlled by a gate that opens in response to a specific 
combination of proteins. This way, robots undergo a conformational change, expose their inner payload and 
make it available to engage target cells. The gate can be opened also by an external DNA strand that eventually 
activate the robot. This DNA strand (or key) can be loaded into one robot as a payload, and, if it is activated, 
the payload generated by this robot can enter the gate of another robot, thus activating it. These keys can cause 
a positive regulation or a negative regulation on the target robot. In the former case, it may open the gate, 
otherwise it may close or inhibit the opening of the door [72]. The architectures proposed in [72] can process 
only two bits, but through a daisy chain of processors, it is possible increase the overall processing capacity. 
Thus, by properly combining nanorobots, it is possible to obtain the outputs as the basic logical gates (AND, 
OR, NOT, XOR, NAND) and a half adder [73]. 
3.1.4. Antibody-based techniques 
Another promising therapeutic method is the antibody-based drug delivery system (ADDS, [74]), which 
takes inspiration from the human autoimmune mechanisms. Such mechanisms can perform self-diagnosis, and 
allow also destroying the root cause of a disease, in an adaptive fashion. In the approach proposed in [74], the 
antibody-based drugs are artificially engineered in order to act similarly as the natural antibodies [75]. By 
taking advantage of the capabilities of such molecules to bind only with the antigen exposed on the diseased 
cells, it is possible to avoid side effects on healthy cells. 
In [76], the authors extend the PDDS [56] in order to analyze and model the molecular transport on ADDS. 
By modifying the PDDS framework, it is possible to take into account the shape of the antibody molecules in 
order to track the drug propagation with a high temporal and spatial resolution. This is useful for obtaining 
accurate pharmacokinetic and pharmacodynamics models of antibody-based therapies.  
Beside the targeted drug delivery systems, it is also possible to implement stimuli triggered drug delivery 
systems by using aptamers, introduced in Section 2.3. A stimuli-triggered drug release system could both 
improve the effectiveness of therapies and reduce their side effects. When a specific stimulus is detected by 
these systems, drugs are released directly at the specific disease location. Some of such stimuli include specific 
pH and temperature values, ionic strength, redox reagents, specific disease targets, light, and magnetic field. 
  
A pH-triggered aptamer drug delivery system is illustrated in [52]. This kind of stimuli-triggered feature could 
be exploited also by nano-control nodes, which could encode the control messages through the modification 
of the local physical conditions in the site of interest, instead of releasing molecular signals, for triggering drug 
release. 
3.1.5. QD and FRET-based techniques 
Special kinds of fluorescent molecules find application in the photodynamic therapy (PDT) of cancer as 
actuators. Specifically, in PDT based on quantum dots, an excited dot transfers its optical energy to a 
conjugated photosensitizing agent which, subsequently, synthesizes a reactive singlet oxygen via energy 
transfer [77]. Through a well-planned excitation of quantum dots, it is possible to produce oxygen near to 
cancer cells, thus triggering the apoptotic process that brings these cells to death. By such mechanism, it is 
possible to develop a network composed by molecular sensors and actuators, in which mobile bioluminescent 
sensors transfer the information to fluorophore-based actuators, which can perform the appropriate actions. In 
particular, nanosensors may generate luminescent messages in order to notify actuators of a threat (e.g. a 
tumor). 
Recent advances have led to the development of multifunctional nanoparticle probes that are very bright 
and stable under complex in vivo conditions. A new structural design involves both the encapsulation of 
luminescent QDs with amphiphilic block copolymers and combination of polymer coating to tumor-targeting 
ligands and drug delivery capabilities. Polymer-encapsulated QDs are essentially nontoxic to cells and animals, 
but their long-term in vivo toxicity and degradation need more studies [46]. 
3.2. Immune System Activation 
In recent years, the interactions between immune cells have inspired a strand of research on the use of such 
mechanisms for nanoscale communications. Indeed, the immune system is composed by several types of cells 
able to perform specific tasks in order to defeat pathogens and other threats. Each immune cell type is 
specialized against specific threats and can be triggered by a cascade of signaling molecules released by 
specific immune cells, specialized in the recognizing specific pathogens. The immune system triggers not only 
reactions aiming to eliminate bacteria and viruses, or to clean infected cells, but also specific actions to 
eradicate tumor cells or any foreign body that is incompatible with the defended organism. The fundamental 
mechanisms underlying the defensive phenomena are essentially two: 
- the cell or cell-mediated immunity, which is formed by cells with phagocytic activity; 
- the humoral immunity, made of antibody molecules produced by the immune system. 
By means of molecular transmissions from artificial nanomachines, it was proposed to trigger the immune 
response in order to intensify the utilization of its fighting capabilities against specific threats [78]. 
  
In [17] the authors have analyzed a mechanism for activating the humoral response through the activation 
of the T-lymphocytes [79][80]. These cells release molecules that produce a positive feedback which amplifies 
the signal delivered to the B-lymphocytes, which release antibodies. 
Conversely, in some situations it is necessary to inhibit the immune response, by releasing molecules that 
can reduce the immune activities, or mitigate the immune response, by hindering the carrier propagation and 
absorption by using artificial antagonists. Such antagonists, that could be released by nanomachines, affect the 
assimilation phenomena in three ways: 
- The receptor antagonists can bind to them, thus making them busy with any further assimilation, 
without activating it. In this way, any excitation stimulus vanishes [85][86]. 
- Soluble receptor antagonists can bind to the activation molecules, making carrier binding with the 
compliant receptors impossible [82][83]. 
- A set of decoy receptors are used to capture the activation molecules, not allowing them to reach the 
target cells [84]. 
Similarly to drug delivery applications, also for immune system activation it is possible to identify three distinct 
groups of functions: actuator, monitoring, and control (see Figure 1). 
 
3.3. Tissue Engineering 
Recently, significant research efforts have been dedicated to some technologies that allow engineering of 
tissues, and can lead to organ construction [87][88]. If successful, given the actual shortage of organs, these 
technologies could provide alternative treatments for patients with organ and tissue failure. Nanomachines 
embedded inside such engineered organs may produce smart organs, which allow detecting diseases. 
A very interesting and minimally invasive application in this area is the detection of biological functions in 
cells, tissues, and organs, by monitoring the calcium ions behavior. Indeed, short-range communications 
obtained through calcium signaling is one of the most studied diffusion-based communications, where 
information is typically encoded by modulating ion concentration [89]. In recent years, research has focused 
on communications between nanomachines that may interface with tissues within organs by means of calcium 
ions [90][91]. In [92], the authors analyze the effects that tissue deformations have on the calcium ions 
propagation. Indeed, this molecular exchange is very common in intracellular communications (e.g. see [93]) 
and the transmission reliability depends on the state of the physical tissue structure. A set of nanomachines 
embedded into a tissue may collect information about the current state of the tissue, and use the statistics 
collected from the communication between different nanomachines in the network. To this aims, the authors 
propose a molecular nanonetwork inference process in order to determine the quantity and type of deformation, 
the concentration of the released ions, and the communication distance between source and receiver nodes. 
Since the structure of the tissues is composed by a tight formation of interconnected cells, any change in the 
  
structure of a cell could influence the whole tissue. In fact, the propagation of calcium ions, which diffuse 
within these tissues, depend largely on the inner spatial volume of the cells that compose the whole tissue. 
Therefore, any physical perturbation that affects the cell volume can also affect the communication capacity.  
Nanomachines envisaged for such a scenario could be either biological or artificial. For the last ones, 
artificially assembled nanodevices can be implemented by using the nano-electromechanical systems (NEMS) 
technology. These devices, embedded into a tissue, could externally activate the release of calcium ions by 
using needles or force probes [94][95]. Even receivers could be implemented by using NEMS devices. 
The tissue engineering has a primary role also in the field of the regenerative medicine [96]. Its primary 
goals are the replacement of damaged tissues and organs by using recruited cells or transplanted cells directly 
on the damaged site. Cellular signaling is fundamental in the development of tissues. This signaling mainly 
consists of diffusion-based molecular communications, but also mechanical cues and direct cell-to-cell 
interactions are involved in such processes. In particular, the molecules involved (peptides and proteins), act 
as potential therapeutics, regulate the absorption of soluble growth factors, and the adhesion, the migration, 
the proliferation, and the differentiation of a multitude of cell types. All these elements are involved in tissue 
engineering [97], and allow controlling the response of cells so as to control the formation of new tissues. Even 
the transplantation of cells able to release the desired growth factors has been proposed [98]. 
The effectiveness of the growth factors on the tissue repair process need a further analysis. Indeed, it is 
known that such factors are crucial for the control of a multitude of biological processes, included the tissue 
regeneration. Nevertheless, they have a short life once released in the body, since they are rapidly eliminated 
[99]. Success of tissue regeneration depends on the exposure time to such factors. The highest regeneration 
rate is obtained by an exposure that lasts for the whole repair process. For this reason, a set of controlled 
delivery systems able to release the growth factors, have been developed in order to prolong the tissue exposure 
and to maintain the concentration of these factors nearly constant [100]. 
A specific scope for the tissue engineering is neovascularization, which is crucial for the treatment of many 
coronary artery diseases. Through a deeper study on the angiogenesis phenomena, it was possible to identify 
many growth factors involved. Anyway, angiogenesis depends of a multitude of signaling molecules (i.e. 
cytokines) that behave in a coordinated manner. 
Even bone regeneration has been considered in order to accelerate the regeneration process and to control 
the such a process in situations of incomplete regeneration. Medical researchers have found that magnetic 
nanoparticles coated with targeting proteins (ligand for molecular communications) can stimulate stem cells 
to regenerate bone. The regeneration process is maintained through the release of growth stimulant [101]. 
The potential applications include also wound healing, which consists of regenerating the skin tissue after 
ulcers, scars or burns. The task coordination between the bionanomachines implementing these functions can 
be accomplished through molecular communications, which allow realizing the precise release and control in 
space and time of growth factors and cytokines that allow shaping of tissues and organs. 
  
Similarly as was done for drug delivery applications and immune system activation, also for tissue 
engineering three distinct groups of functions/nodes can be identified: actuators (e.g. for delivery of grow 
factors), monitoring (e.g. calcium ions monitoring), and control (e.g. rate control of grow factor via release of 
proteins).  
3.4. Nanosurgery 
A set of coordinated nanomachines, equipped with specific actuators and instruments, was conceived to 
perform nanosurgery interventions from the inside of the patient’s body [102]. These nanomachines can be 
managed from the external through compatible interfaces under the supervision of human surgeon, acting as a 
semi-autonomous on-site system correcting lesions by nanomanipulation. 
In this way, high precision intracellular surgeries, which are unfeasible through direct human manipulation, 
can be accomplished. These devices could realize interventions such as removal of microvascular obstructions, 
reconditioning of vascular endothelial cells, noninvasive tissue and organ transplantation, reparation of 
damaged extracellular and intracellular structures, and even replacement of chromosomes inside human cells 
[103]. 
In addition, also atomic force microscopy (AFM) can be extremely useful in nanosurgery applications, by 
taking advantage of its bioconjugation capabilities coupled with active assembly and analysis of 
bioconjugation-based nanostructures [104]. In particular, in [103] the authors have proposed an AFM-based 
nanorobot with integrated imaging, manipulation, analysis, and tracking functions, important for cellular-level 
surgery on live samples. It is a sort of augmented reality system that includes the possibility of having a visual 
feedback for monitoring dynamic changes on a sample surface. This nanodevice was demonstrated to be able 
to both deliver epidermal growth factor (EGF) to a cell and subsequently measure the elasticity response of 
cells contacting the stimulated cell.  
4. Implementation Mechanisms and Interfaces 
An open research issue in molecular communications aims to design suitable interfaces able to interconnect 
the nanoscale biological environment with the external world (outside the body). Such interfaces are conceived 
for monitoring and controlling intra-body nanodevices by means conventional external devices. 
One of the proposals [20] assumes the cardiocirculatory system to be the transmission medium. This 
proposal uses a number of mobile, circulating nanomachines, which act as sensors, and a smart, fixed probe, 
disposed along a blood vessel, which act as the sink for the information collected by the sensors. After the 
probe has received specific signals from the circulating nanomachines, it delivers their information content to 
the external, as depicted in Figure 3. Considering the drag effect of the blood flow and the relatively high 
propagation times required to complete a successful transmission, the smart probe should be able of capturing 
the circulating nanomachines and keep them stuck to its surface at least for the time required to complete the 
transmission. This is possible by exposing suitable adhesion molecules on the smart probe surface. In such a 
  
scenario, the smart probe can trigger the communication from the mobile nanomachines stuck on its surface 
through the release of activation messages. The smart probe may collect several messages coming from 
different circulating nanomachines before releasing the overall information to the outside. This information 
could be encoded by the intensity of the received messages. In particular, a large amount of activated 
nanomachines, emitting the same signal (e.g. detection of tumor cells), will rise the alarm level. Each detected 
phenomenon can be coded through a specific pattern of molecules, so as to discern between a significantly 
large of biological parameters and extract the desired information from their joint processing. The information 
stored on each mobile nanomachine is cleared after its release to the smart probe. On the other hand, the smart 
probe may decide to release the collected information to the outside after a given number of assimilations. The 
externally controlled smart probe could be also used to control nanomachines, by transmitting commands that 
modify their inner state and their behavior. 
Another further proposal consists of the dermal display, which envisages the use of a large number of 
bionanomachines embedded just few microns below the epidermis. It is therefore possible to obtain an 
interactive display, a few centimeters wide, able to both respond to the touch of a finger and emit visible 
photons in order to display the desired information over the skin [105]. The finger touch is an external stimulus 
that triggers a mechanical signal able to activate the bionanomachines that, through the molecular 
communication, carry health information. More precisely, the system makes use of two kind of interfaces, the 
first one is used for nanomachines to nanomachines communication (required for nanomachine interaction and 
coordination), and the second one refers to the inbound and outbound messages through the skin. The inbound 
interface converts signals from the external into chemical ones, while the outbound interface converts the 
chemical signal generated by nanomachines (i.e. molecular signals) into conventional electrical or optical 
signals. As for the inbound signals, a set of special materials can be used for realizing the transduction process. 
For example, photosensitive materials can convert optical signals transmitted by external devices into chemical 
signals that can be received by nanomachines. For instance, specific wavelengths can activate photoactivable 
proteins [106], and caged-compounds release encapsulated molecules through bond breaking [107]. Even 
temperature-sensitive materials could be very useful, since they can convert external thermal signals into 
chemical ones. A temperature increase can induce a conformational change on temperature-sensitive 
liposomes and dendrimers [108], thus causing depletion of their inner structures, through the release of 
molecules. In [105] the authors propose an approach where artificial materials are embedded into the cell 
cytosol in order to use those materials as interfaces (ART: artificially synthesized materials). They are believed 
to give more predictable responses to incoming and outcoming messages, compared to a genetically engineered 
solutions. Figure 6 shows a scheme of the input-output architecture proposed in [105]. 
By means of specific interfaces, it was proposed to connect biological nanonetworks not only with external 
devices, but also to the Internet, thus realizing the so-called Internet of Biological Nano Things [109]. 
  
 
Figure 6: The architecture of the molecular communication system externally controlled by a dermal display 
 
Finally, even magnetic materials are considered suitable signal transducers, since they can convert external 
magnetic signals into chemical ones. In this case, an external radio-frequency magnetic fields may cause 
reactions on gold nanocrystals attached to the DNA molecules and induce the hybridization/dehybridization 
process of the DNA molecules [110]. Bionanomachines integrated with these materials can react to the 
generated DNA molecules and thus respond to magnetic signals. 
For the outbound interface, luminescent materials can be used for converting chemical (molecular) signals 
into optical signals to be sent to external devices. In this case, the bioluminescent molecules catalyze chemical 
reactions, through consumption of chemical energy (e.g. ATP), emitting light photons [111]. 
A recent study shown in [112] is focused on the use of sweat for diagnostic purposes. The main idea arises 
from the knowledge that sweat contains a huge amount of medical information, which is updated in real time. 
Indeed, since 1970s, several studies tried to use the sweat to monitor drug levels inside body. Taking inspiration 
from this, it was proposed a more controllable way to collect health information, by means the stimulation of 
perspiration using an engineered patch, which is also able to analyze the collected information. This patch is 
also capable of transmitting results to a remote device wirelessly (i.e. to a smartphone) thus creating a portable 
and easy to use monitoring system. It has been developed at the University of Cincinnati [112], and makes use 
of paper microfluidics to wick sweat from the skin through a specific membrane able to select only the desired 
ions. A specific circuitry is installed over the patch for both processing the collected samples and sending data 
to an external device. The onboard chip is externally powered similarly as in RFIDs. This kind of interface 
could be very useful for real time monitoring in different applications, such as those used in athletics and 
military fields. Figure 7 illustrates the layout of the engineered patch. 
 
  
 
Figure 7: The engineered patch able to collect and analyze the skin sweat in real time. Indeed, the ions contained into the sweat drops 
are processed by the onboard chip and finally the relevant health information is transmitted to an external device. 
 
An interesting strand of research on bacteria-based communications consists of making use the quorum 
sensing mechanisms used by bacteria for coordinating colonies. It is a decentralized process, which allows 
bacteria to estimate their density and to regulate their behavior for obtaining some desired macroscopic effects. 
An example of a coordinated task is the emission of light signals by the synthesis of the Green Fluorescent 
Protein (GFP). This mechanism could be used for establishing communications from implanted nanomachines 
to the outside world [113]. By encoding information through the concentration of Acyl Homoserine-Lactone 
(AHL) molecules, it is possible to trigger each bacterium to produce GFP with an intensity that depends on the 
concentration of assimilated AHL molecules. This feature could also be added also in bacteria that normally 
does not emit GFP, through the configuration of their plasmid [113]. 
A recent research, lead by the Google X project, proposes the use of wearable devices equipped with a 
magnet able to attract and count the magnetic nanoparticles released in a body [114]. In this way, nanoparticles 
can release the collected information, for example about a detected cancer or any other diseases, to the wearable 
device. The monitoring nanoparticles may be introduced in the human body by taking a pill. Google 
researchers intends to obtain a proactive medicine, rather than reactive, through a monitoring system of the 
physiological conditions, integrated in the Google Fit Platform [115]. 
Finally, Table 1 summarizes the main enabling technologies for the applications mentioned above 
(associated with rows), showing for each one the available implementation options (associated with columns), 
ranging from the FRET/QD to the protein-based. This table aims to provide a global picture of the current state 
of the art technologies that can be used for implementing the specific medical applications identified in our 
taxonomy. For each application reported in Table 1 we summarize the most promising implementation options 
illustrated so far. It is worth to note that Table 1 represents the current state of the art. The reported information 
  
does not imply that some of the presented technologies in the near future cannot have another medical 
application. 
For what concerns the imaging techniques used for detecting both diseases and other specific markers, the 
FRET technology and QDs provide interesting solutions, since external devices can easily measure the 
intensity of light signals. Also antibodies are good implementation options to advanced imaging techniques. 
For instance, they allows implementing the MRI virtual biopsy technique by using a nanoconjugate carrying 
MRI contrast agent and antibodies recognizing tumor-specific markers. A similar method is used with chemical 
antibodies (aptamers). Disease detection can be performed in different ways, including the use of engineered 
bacteria sensible to specific disease (e.g attracted by tumors lysates), and the use of molecular communication 
receivers, consisting of nanomachines, which expose surface receptors compliant with cytokines and 
antibodies released from damaged tissues, infected cells, and immune system cells. Personalized diagnosis can 
be performed by analyzing the release of proteins that reflect the health condition of a patient. On the basis of 
release pattern observed, it is possible to build an in-silico model for predicting evolution of diseases. By using 
nanomachines as actuators (nanorobots) damaged tissues and organs can be repaired from the inside of the 
human body. This is commonly included in the field of nanosurgery applications. Another instance of medical 
applications is the targeted release of drugs, which can reduce the amount of medicaments required to treat a 
disease. Engineered bacteria, viruses, and nanomachines can release drugs in a controlled fashion, thus 
implementing a bio cyber-physical system. In addition, even modified antibodies and proteins can be released 
in order to trigger specific behaviors on the target sites. More specifically, it has been demonstrated that the 
release of specific proteins and growth factors could control the tissue engineering process. Finally, it could 
be sufficient to trigger the immune system response to remove pathogens and disease conditions more 
efficiently than it happens spontaneously. This could be obtained by the coordinated action of engineered 
bacteria, antibody, and viruses, that, after the recognition of an external threat, could release specific molecules 
(proteins) or RNA strands which alert the immune cells. 
 
Medicine applications 
Implementation options through molecular communications 
FRET/QD Bacteria Virus Antibody Nanorobot Protein-based 
Imaging x   x   
Disease detection  x  x  x 
Personalized diagnosis      x 
Nanosurgery     x  
Drug delivery  x x x x x 
Tissue engineering      x 
Immune system activation  x x x  x 
Table 1: Implementation options for main medical applications. 
 
  
5. More visionary applications 
A novel cancer therapy envisages the use of DNA nanorobots inoculated into a diseased patient. The 
nanorobots, which are developed in order to not cause an immune response, can perform simple surgery on  
diseased cells. Moreover, these nanorobots could be combined with toxic drugs for an effective delivery. By 
means of DNA origami and molecular programming, the nanorobots can discover and kill cancer cells, taking 
advantage from the reciprocal coordination, generating logical outputs [116]. 
Molecular communications could also support to the treatment of pain. Indeed, each year many people 
suffer the pain effects, which leads to work disability by causing a loss in productivity. The pain is a perception, 
so the idea is to block this perception. The traditional approach makes use of powerful morphine-based 
painkillers that cause severe side effects on the body, including nausea, vomiting, and constipation. Opioids 
block pain by binding to 'mu-receptors' in the brain. However, they also bind to mu-receptors in the bowels, 
and this causes constipation. People with chronic pain need to think outside of the opioid/narcotic pain box. 
There are also treatments besides narcotics to help chronic pain such as antidepressants. Depending on the type 
of pain, even some cardiac drugs are effective. For these reasons, an effective contribution on the treatment of 
pain could rise from the monitoring of the pain interest region with probe based monitoring, optogenetic light 
switch, and bacteria releasing localized drugs via the optogenetic activation. By such a system, the drug 
delivery will be determined through a personalized process, driven by optimization techniques and computing. 
It will be targeted to the specific needs, tolerance to drugs, pain extension, life style (e.g. smoke, alcohol, …). 
In this way, the treatment will focus on pain type and extension of the interested area. This will improve the 
quality of life, since no drug flooding through the whole body will be allowed. Psychological issue typically 
determined by pain treatment will be avoided or minimized. Moreover, the treatment could happen at home, 
by minimizing medical interaction besides the initial configuration and triggering. This means a significant 
cost reduction for the national health systems, due to both the reduced amount of drug used and effectiveness 
of treatment. The medical personnel could be also alerted through smartphone driven by the implanted 
controller in case the results of treatment is not satisfactory. As presented above, both mobile sensors and 
actuators (drug releasers) will be bio-compatible devices, degradable through specific enzymes, avoiding the 
activation of the immune response and any other side effects. This approach could be also a significant 
component of other treatments where significant pain is expected, thus improving effectiveness and 
acceptability by patients. 
Future research directions in the monitoring of the biological parameters can envisage the analysis of the 
circulating RNA naturally released by healthy and diseased cells through the exosomes [34]. In more detail, it 
is known that cancer cells frequently release modified RNA strands that could be collected by 
bionanomachines (e.g. engineered bacteria, nanorobots, smart probe receptors, and so on), which are 
previously configured with the 'original' copy of the patient DNA. In this way, the captured RNA strands are 
compared with the healthy version of the DNA allowing the detection of any not matching pattern. This could 
be an alternative way for cancer monitoring and identification, without any loss of generality. In fact, also the 
  
non tumoral cells could suffer a degradation/overwriting of their nuclear DNA, caused by malicious bacteria 
and viruses. Indeed, many viruses deploy mechanisms designed to evade pathogen-sensing pathway, in order 
to spread the viral infection [117], enclosing their RNA into secreted vesicles and exosomes. Such monitoring 
system could also give information about the nature and identity of such viruses, simplifying not only the 
diagnosis of the disease but also triggering the release of medicaments and drugs. 
A further promising technology, which can promote innovative health care applications, consists of using 
the so-called clustered, regularly interspaced short palindromic repeats (CISPR). They are DNA sequences 
containing short repetitions of base sequences, separated by short segments of DNA, which have been obtained 
from previous exposures to viruses [118]. They can be found in many bacteria and most of archaea, which are 
single-celled prokaryotic microorganisms. CRISPRs constitute a sort of "genetic memory" used to reject new, 
returning, and ever-present invading DNA molecules. CRISPRs have been identified as the underlying 
mechanism of a genetic interference pathway that limits gene transfer and protect cells from bacteriophages 
and conjugative plasmids. In summary, they implement an efficient antiviral defense mechanism, acting like 
an immune system. Furthermore, the CRISPR interference can be even reprogrammed in order to reject the 
invading DNA molecules that have not been still encountered. Potential health-care applications are numerous, 
and are essentially related to the combined use of molecular communications and CRISPR to rewrite human 
genes for obtaining innovative treatments. Potential targets of CRISPR-based treatments are genetic diseases, 
such as cystic fibrosis and sickle-cell anemia, which are caused by single base pair mutations [119]. 
Finally, another important application field for the health monitoring is given by the communicome, which 
is the technique that control a large amount of communication factors in the plasma of patients. The cytokines, 
chemokines and growth factors, which are members of the molecular network, may have different expression 
levels in patients with neurological diseases compared with those found in healthy people. The measures 
performed on both healthy people and Alzheimer's disease patients show that it is possible to identify small 
groups of factors that give a sort of signature of the disease [120]. Using proper nanomachines, this non-
invasive technique is exploitable in plasma or other fluids over the course of a neurological disease and may 
provide information about pathophysiological processes. 
In spite of the huge research effort made in recent years, there are still a lot of open challenges on this field. 
At first, the development of a complete nanomachine is yet tricky. Indeed, the design of such devices involves 
multidisciplinary expertise in the biological, medicine and engineering fields. In the nature, similar devices are 
available but forcing them to perform the desired behavior requires a high customization capability of the 
intracellular compartments and of the cellular physiology. Nanotechnologies have to reach a degree of 
maturation, which allows, in the next years, the development of bio-hybrid or even full hybrid devices. Indeed, 
current researches are based on several subunit that are yet to come, such as the elaboration unit of the 
nanomachines, which has to process the collected information and take decisions based on these. Several 
proposals on biological logic gates have been done, but their physical implementation is still in its infancy, 
and currently unavailable on large scale. We could expect that such elaboration units have to be enough 
  
powerful to accomplish all the desired tasks, but also tiny and with low energy consumption. In more detail, 
the last issue deserves attention, since the energy harvesting in a biological environment is a complete new 
research field, which could take inspiration from the ATP cycle in cells. In this way, it could be possible to 
obtain chemical energy, which could be exploited both for processing and for motion and other core functions. 
In case of active motion, this could be obtained by one or more artificial flagella, which rotates at the required 
speed acting like a propeller, thus supporting both motion and direction control.  
Also information storing is a process that consumes energy and space in a nanomachine. Thus, storing 
capacity and the rate of storing require special attention. One interesting proposal consists of DNA storing, 
since it is a very reliable molecule, able to store a very high amount of information for a very long time, through 
base pair coding. How to control this process in a hybrid device is still an open issue. 
Communication units have still to be suitably designed at physical level. Indeed, the ligand-receptor binding 
process, and also the exosome and endosomal release and uptake, have to be induced and controlled to obtain 
the desired behavior. Moreover, molecular communications require a huge amount of molecules for each 
transmitted message and, for this reason, the released molecules are to be considered a finite resource that has 
to be continually replenished, locally produced, and/or recycled. In nature, the biological cells accomplish this 
task by recycling the internal and absorbed proteins, assembling the molecular chains by means the mRNA 
sequence and by using complex molecular machines, such as ribosomes. These units are very complex, and a 
complete artificial ribosome requires a huge effort in the nanotechnology field. 
On the communication side, there are many open challenges, such as the rate control strategies, that are 
able to control the emission of information molecules according to the environmental conditions. Moreover, 
the communication scenarios analyzed so far are very simple and complete communication protocols able to 
handle the multi access interference are yet to come. This is a required step to obtain concurrent transmission 
between multitudes of nodes in the same channel. In addition, also the mechanisms able to increase the 
reliability on the received information are missing, on both among nanomachines and with external interfaces. 
Since the analyzed scenarios are essentially biological, the biocompatibility of such devices have to be 
analyzed carefully, in order to avoid any side effects on tissues and organs. Moreover, these devices have to 
be able to degrade themselves naturally when their services are no longer required. A reliable shutdown process 
has to be developed in order to tear down all the connections and to stop all actuation services [121]. 
 
6. Conclusion 
This paper surveys the medical applications being developed by leveraging on molecular communications. 
In addition to showing that new significant progresses have been achieved in the fields of diagnosis and 
treatment, we aim at stimulating further research in this promising and challenging area. In this regard, we 
  
have stressed the role of interdisciplinary research and how in-vitro and/or in-silico joint experiments can be 
used for assessing most of the techniques illustrated, essentially for discovering any  unexpected phenomena. 
Based on current achievements, we have both proposed a taxonomy of medical applications and identified, 
for each one, the existing implementation technologies.  
Finally, we have explored a number of more advanced and visionary medical applications, along with 
relevant open research issues relevant to molecular communications, with an attempt of identifying future and 
more ambitious applications, with an expected significant impact on society. 
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